Synthesis and calcium channel antagonist activity of novel 1,4-dihydropyridine derivatives possessing 4-pyrone moieties

Medicinal Chemistry Research

Volumn 21, Issue 3, 2012, Pages 284-292

  Shahrisa, Aziz ^a   Miri, Ramin ^b   Esmati, Somayeh ^a   Saraei, Mahnaz ^a   Reza Mehdipour, Ahmad ^b   Sharifi, Maryam ^b  

^a UNIVERSITY OF TABRIZ   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,4 dihydropyridine; 4 pyrone carbaldehyde; 4H pyran 4 one; Calcium channel antagonist

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 4 (4 OXO 6 PHENYL 4H PYRAN 2 YL)BENZALDEHYDE; 4 (6 METHYL 4 OXO 4H PYRAN 2 YL)BENZALDEHYDE; 4 OXO 6 PHENYL 4H PYRAN 2 CARBALDEHYDE; 4 PYRONE DERIVATIVE; 6 METHYL 4 OXO 4H PYRAN 2 CARBALDEHYDE; DIETHYL 2,6 DIMETHYL 4 (4 OXO 6 PHENYL 4H PYRAN 2 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIETHYL 2,6 DIMETHYL 4 (6 METHYL 4 OXO 4H PYRAN 2 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIETHYL 2,6 DIMETHYL 4 [4 (6 METHYL 4 OXO 4H PYRAN 2 YL)PHENYL] 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIETHYL 2,6 DIMETHYL [4 (4 OXO 6 PHENYL 4H PYRAN 2 YL)PHENYL] 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (4 OXO 6 PHENYL 4H PYRAN 2 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (6 METHYL 4 OXO 4H PYRAN 2 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 [4 (6 METHYL 4 OXO 4H PYRAN 2 YL)PHENYL] 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL [4 (4 OXO 6 PHENYL 4H PYRAN 2 YL)PHENYL] 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; ETHYLMETHYL 2,6 DIMETHYL 4 (4 OXO 6 PHENYL 4H PYRAN 2 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; ETHYLMETHYL 2,6 DIMETHYL 4 (6 PHENYL 4 OXO 4H PYRAN 2 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; ETHYLMETHYL 2,6 DIMETHYL 4 [4 (6 METHYL 4 OXO 4H PYRAN 2 YL)PHENYL] 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; ETHYLMETHYL 2,6 DIMETHYL [4 (4 OXO 6 PHENYL 4H PYRAN 2 YL)PHENYL] 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; GUINEA PIG; MALE; NONHUMAN;

EID: 84861851936     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9534-8     Document Type: Article

References (55)

1. Amini M, Golabchifar AA, Dehpour AR, Pirali HM, Shafiee A (2002) Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents. Arzneimittelforschung 52:21-26 (Pubitemid 34084489)
2. Arimoto H, Nishiyama S, Yamamura S (1990) Mild conditions for cyclization of β-triketides to the corresponding γ-pyrones carrying adjacent chiral centers toward biomimetic synthesis of fully substituted γ-pyrone-containing natural products. Tetrahedron Lett 31:5619-5620 (Pubitemid 20278612)
3. Baranda AB, Alonso RM, Jimènez RM, Weinmann W (2006) Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. Forensic Sci Int 156:23-34 (Pubitemid 43061280)
4. Bossert F, Vater W (1989) 1,4-Dihydropyridines-a basis for developing new drugs. Med Res Rev 9:291-324 (Pubitemid 19189686)
5. Budriesi R, Bisi A, Ioan P, Rampa A, Gobbi S, Belluti F, Piazzi L, Valenti P, Chiarini A (2005) 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety. Bioorg Med Chem 13:3423-3430 (Pubitemid 40552862)
6. Caron S, Vazquez E (2003) Efficient synthesis of [6-chloro-2-(4- chlorobenzoyl)-1H-indol-3-yl]-acetic acid, a novel COX-2 inhibitor. J Org Chem 68:4104-4107 (Pubitemid 36576672)
7. Caturla F, Amat M, Reinoso RF, Calaf E (2006) Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors. Bioorg Med Chem Lett 16:3605-3608 (Pubitemid 43777123)
8. Edraki N, Mehdipour AR, Khoshneviszadeh M, Miri R (2009) Dihydropyridines: evaluation of their current and future pharmacological applications. Drug Discov Today 14:1058-1066
9. Garey D, Ramirez M, Gonzales S, Wertsching A (1996) An approach to substituted 4-hydroxypyran-2-ones: the total synthesis of phenoxan. J Org Chem 61:4853-4856 (Pubitemid 26247685)
10. Gaudio AC, Korolkovas A, Takahata Y (1994) Quantitative structureactivity relationships for 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues): a quantum chemical/classical approach. J Pharm Sci 83:1110-1115 (Pubitemid 24247347)
11. Gordeev MF, Patel DV, Gordon EM (1996) Approaches to combinatorial synthesis of heterocycles: a solid-phase synthesis of 1,4-dihydropyridines. J Org Chem 61:924-928 (Pubitemid 26066987)
12. Groundwater PW, Solomons KRH (1994) The synthesis of pyranoacridinone inhibitors of protein tyrosine kinases. J Chem Soc Perkin Trans 1:173-177
13. GuptaV,MisraU(2008) Synthesis and cardiovascular activity of diflurosubstituted hexahydroquinoline. Med Chem Res 17:437-444
14. Hantzsch A (1882) Uber die synthese pyridinartiger verbindungen aus acetessigather und aldehyammoniak. Justus Liebigs Ann Chem 215:1-82
15. Harris TM, Murphy GP, Poje AJ (1976) Formation of trianions of 2,4,6-triketones. Synthesis of 3,5,7-triketo acids using lithium diisopropylamide. J Am Chem Soc 98:7733-7741
16. Hemmateenejad B, Mirri R, Safarpour MA, Khoshneviszadeh M, Edraki N (2005) Conformational analysis of some new derivatives of 4-nitroimidazolyl-1,4- dihydropyridine-based calcium channel blockers. J Mol Struct Theochem 717:139-152 (Pubitemid 40348649)
17. Hobuss D, Laschat S, Baro A (2005) Concise two-step synthesis of g-Pyrone from acetone. Synlett 16(1):123-124 (Pubitemid 40094900)
18. 2+ channel antagonists. J Med Chem 25:775-785 (Pubitemid 13100458)
19. Kamino T, Kuramochi K, Kobayashi S (2003) A concise approach to 5-substituted-4-pyrones from kojic acid. Tetrahedron Lett 44: 7349-7351 (Pubitemid 37088043)
20. Kumar A, Maurya RA (2008) Efficient synthesis of Hantzsch esters and polyhydroquinoline derivatives in aqueous micelles. Synlett 6:883-885 (Pubitemid 351518053)
21. Lavilla R (2002) Recent developments in the chemistry of dihydropyridines. J Chem Soc Perkin Trans 1:1141-1156 (Pubitemid 35038408)
22. Dorman LC (1967) Synthesis of 2-methyl-4H-pyran-4-one. J Org Chem 32:4105-4107
23. Legeay JC, Eynde JJV, Bazureau JP (2007) Sequential synthesis of a new analogue of amlodipine bearing a short amino polyethyleneglycol chain. Tetrahedron 63:12081-12086 (Pubitemid 47577483)
24. Li CS, Lacasse E (2002) Synthesis of pyran-4-ones from isoxazoles. Tetrahedron Lett 43:3565-3568 (Pubitemid 34442357)
25. Light RJ, Hauser CR (1960) Aroylations of beta-diketones at the terminal methyl group to form 1, 3, 5-triketones. cyclizations to 4-pyrones and 4-pyridones. J Org Chem 25:538-546
26. Mager PP, Coburn RA, Solo AJ, Triggle DJ, Rothe H (1992) Diagnostic statistics and molecular modelling of 1,4-duhydropyridine calcium channel antagonists. Drug Des Discov 8: 273-289
27. Manhold R, Jablonka B, Voigdt W, Schoenfinger KF, Schravan K (1992) Calcium- and calmodulin-antagonism of elnadipine derivatives: comparative SAR. Eur J Med Chem 27:229-235
28. Mason RP, Trumbore MW, Mason PE (2000) Membrane biophysical interaction of amlodipine and antioxidant properties. Drugs 59:9-16
29. Mehdipour AR, Javidnia K, Hemmateenejad B, Amirghofran Z, Miri R (2007) Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities. Chem Biol Drug Des 70:337-346 (Pubitemid 47537694)
30. Miri R, Niknahad H, Vesal G, Shafiee A (2002) Synthesis and calcium channel antagonist activities of 3-nitrooxyalkyl, 5-alkyl 1,4-dihydro-2,6- dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3,5-pyridinedicarboxylates. Farmaco 57:123-128 (Pubitemid 34175110)
31. Mohajeri A, Hemmateenejad B, Mehdipour A, Miri R (2008) Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS. J Mol Graph Model. 26:1057-1065 (Pubitemid 351374846)
32. Nguyen JT, Velázquez CA, Knaus EE (2005) Synthesis of fluorinated 1-(3-Morpholin-4-yl-phenyl)-Ethylamines. Bioorg Med Chem 13:1725-1738
33. Pattan SR, Purohit SS, Rasal VP, Mallya S, Marihal SC, Khade AB, Paschapur MS (2008) Synthesis and pharmacological screening of some 1,4-dihydropyridine and their derivatives for anticonvulsant activity. Indian J Chem B 47:626-629
34. Puerta DT, Mongan J, Tran BL, McCammon JA (2005) Potent, selective pyrone-based inhibitors of stromelysin-1. J Am Chem Soc 127:14148-14149 (Pubitemid 41457556)
35. Ricardo MAG, Andreo MA, Cavalheiro AJ, Gamboa IC, Bolzani VS, Silva DH (2004) Bioactive pyrones and flavonoids from Cryptocarya ashersoniana seedlings. Arkivoc (vi): 127-136 (Pubitemid 39363896)
36. Rudas M, Fejes I, Nyerges M, Szollosy A, Toke L, Groundwater PW (1999) Substituent effects on the 4 pi + 2 pi cycloadditions of 4H-pyran-4-one derivatives. J Chem Soc Perkin Trans 1:1167-1172
37. Santander-G IP, Nuńez-Vergara LJ, Squella JA, Navarrete-Encina PA (2003) Synthesis of New 4-Nitrosophenyl-1,4-dihydropyridines of Pharmacological Interest. Synthesis: 2781-2784
38. Sausins A, Duburs G (1988) Synthesis of 1,4-dihydropyridines by cyclocondensation reactions. Heterocycles 27:269-289
39. Sawada Y, Kayakiri H, Abe Y, Mizutani T, Inamura N, Asano M, Hatori C, Arsmori I, Oku T, Tanaka H (2004) Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks. J Med Chem 47:2853-2863 (Pubitemid 38656738)
40. Shahrisa A, Saraei M (2009) Synthesis of pyrone carbaldehydes, pyrone sulfonium ylides and related epoxides. J Heterocyclic Chem 46:268-272
41. Shan R, Velazquez C, Knaus EE (2004) Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl- 3-nitro-4-(2,1,3-benzoxadiazol-4-yl) pyridine-5-carboxylate racemates, enantiomers, and diastereomers. J Med Chem 47:254-261 (Pubitemid 38040509)
42. Soni AK, Krupadanam GLD, Srimannarayana G (2006) Synthesis of new 2-[3-aryl-5-methyl-4-isooxazolyl]-7-hydroxy-3-phenyl-4H-1-benzopyran-4-ones and their insect-antifeedant activity. Arkivoc (xvi): 35-42 (Pubitemid 44833328)
43. South MS, Ma CC, Koeller KJ (2001) Polycyclic aryl and hereroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade. U. S. Patent 6916847, Chem Abstr 135: 303776e
44. Sridhar R, Perumal PT (2005) A new protocol to synthesize 1,4-dihydropyridines by using 3,4,5-trifluorobenzeneboronic acid as a catalyst in ionic liquid: synthesis of novel 4-(3-carboxyl-1Hpyrazol-4-yl)-1,4- dihydropyridines. Tetrahedron 61:2465-2470 (Pubitemid 40228806)
45. Stout DM, Meyers AI (1982) Recent advances in the chemistry of dihydropyridines. Chem Rev 82:223-243
46. Testa R, Leonardi A, Tajana A, Riscassi E, Magliocca R, Sartani A (1997) A novel 1,4-dihydropyridine calcium antagonist for hypertension. Cardiovasc Drug Rev 15:187-219 (Pubitemid 28043996)
47. Triggle DJ (2003a) 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 23:293-303 (Pubitemid 36676276)
48. Triggle DJ (2003b) 1,4-Dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, statedependent interactions, channel isoforms, and other factors. Drug Develop Res 58:5-17 (Pubitemid 36278489)
49. Tu S, Miao C, Fang F, Youjian F, Li T, Zhuang Q, Zhang X, Zhu S, Shi D (2004) New potential calcium channel modulators: design and synthesis of compounds containing two pyridine, pyrimidine, pyridone, quinoline and acridine units under microwave irradiation. Bioorg Med Chem Lett 14:1533-1536 (Pubitemid 38299444)
50. Tyvorskii VI, Bobrov DN, Kulinkovich OG (1998) New synthetic approaches to 2-perfluoroalkyl-4H-pyran-4-ones. Tetrahedron 54:2819-2829
51. Vetelino MG, Coe JW (1994) A mild method for the conversion of activated aryl methyl groups to carboxaldehydes via the uncatalyzed periodate cleavage of enamines. Tetrahedron Lett 35:219-222 (Pubitemid 24037419)
52. Vo D, Matowe WC, Ramesh M, Iqbal N, Wolowyk MW, Howlett SE, Knaus EE (1995) Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4- pyridinylpyridine-5-carboxylate racemates and enantiomers. J Med Chem 38:2851-2859
53. 2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Mol Pharmacol 35:541-552 (Pubitemid 19114973)
54. Yamato M, Hashigaki K, Yasumoto Y, Sakai J (1987) Synthesis and antitumor activity of tropolone derivatives. 6. Structure-activity relationships of antitumor-active tropolone and 8-hydroxyquinoline derivatives. J Med Chem 30:1897-1900 (Pubitemid 18020923)
55. Zawacki FJ, Crim-mine MT (1996) A convenient synthesis of unsymmetrical, substituted c-pyrones from Meldrum's acid. Tetrahedron Lett 37:6499-6502 (Pubitemid 26278272)